SCN9A under Phase 2 in Australia, the Company is Olipass, does anyone reckon this could be competition?
OliPass Peptide Nucleic Acid (OliPass PNA) was derived from PNA by rationally introducing cationic lipid moiety onto nucleobase. By covalently attaching such cationic lipid groups onto PNA, the cell permeability markedly improved. In addition, the affinity for RNA increased by at least a million times.
SCN9A non-opioid painkiller
- Forums
- ASX - By Stock
- PAR
- Competition???
Competition???
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.29M |
Open | High | Low | Value | Volume |
19.5¢ | 20.5¢ | 19.0¢ | $156.2K | 795.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 152244 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 25584 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 152244 | 0.195 |
15 | 319964 | 0.190 |
5 | 127136 | 0.185 |
13 | 1098785 | 0.180 |
8 | 170525 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 25584 | 1 |
0.205 | 34294 | 2 |
0.210 | 54946 | 3 |
0.215 | 252000 | 1 |
0.220 | 17066 | 3 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online